Anti-fibrotic agent (Boehringer Ingelheim International)
N/A
Report date: 2025/06/11 20:01:15
NME
Base Information
Drug NameAnti-fibrotic agent (Boehringer Ingelheim International)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[4]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBoehringer Ingelheim International Gmbh
China Registration ClassN/A
Develop Information
Active CompaniesBoehringer Ingelheim International Gmbh
Inactive CompaniesN/A
Active Indications +[4]
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A